The alterations (gain/amplification) of RAC1 gene in ER-ve BC in the cBioPortal and poor outcome (RFS) data for ER-ve breast cancer cohort suggests the clinical significance of our finding in two independent data sets (Figure 9). Here, RAC1 is linked to breast carcinoma.